Literature DB >> 29967855

Sepsis-Associated Coagulopathy.

Ecaterina Scarlatescu1, Dana Tomescu1,2, Sorin Stefan Arama2.   

Abstract

Systemic inflammatory activation in sepsis often leads to coagulation activation, but the relationship is bilateral, as coagulation also modulates the inflammatory response. This close associate has significant consequences for the pathogenesis of microvascular thrombosis and organ dysfunction in sepsis. While coagulation activation can be beneficial for immune defense, it can also be detrimental once it becomes widespread and uncontrolled. The knowledge of the pathophysiologic mechanisms involved in the interaction between infection and coagulation may lead to the better timing for the administration of targeted antithrombotic therapies in septic patients. This brief review highlights the pathophysiologic pathways leading to the prothrombotic state in sepsis and the mechanisms that play a role in the interaction between infection and coagulation.

Entities:  

Keywords:  coagulopathy; sepsis; thrombosis

Year:  2016        PMID: 29967855      PMCID: PMC5953252          DOI: 10.1515/jccm-2016-0024

Source DB:  PubMed          Journal:  J Crit Care Med (Targu Mures)        ISSN: 2393-1817


  62 in total

1.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

2.  Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.

Authors:  Binggang Xiang; Guoying Zhang; Ling Guo; Xiang-An Li; Andrew J Morris; Alan Daugherty; Sidney W Whiteheart; Susan S Smyth; Zhenyu Li
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.

Authors:  Cristina Lupu; Andrew D Westmuckett; Glenn Peer; Lacramioara Ivanciu; Hua Zhu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

4.  The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.

Authors:  M T Rondina; H Schwertz; E S Harris; B F Kraemer; R A Campbell; N Mackman; C K Grissom; A S Weyrich; G A Zimmerman
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

5.  Blockade of tissue factor: treatment for organ injury in established sepsis.

Authors:  Martha Sue Carraway; Karen E Welty-Wolf; Debra L Miller; Thomas L Ortel; Steven Idell; Andrew J Ghio; Lars C Petersen; Claude A Piantadosi
Journal:  Am J Respir Crit Care Med       Date:  2003-05-01       Impact factor: 21.405

6.  A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.

Authors:  Mineji Hayakawa; Atsushi Sawamura; Satoshi Gando; Subrina Jesmin; Sumiyoshi Naito; Masahiro Ieko
Journal:  Thromb Res       Date:  2012-02-19       Impact factor: 3.944

7.  Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice.

Authors:  Marcel Levi; Janine Dörffler-Melly; Pieter Reitsma; Harry Buller; Sandrine Florquin; Tom van der Poll; Peter Carmeliet
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

8.  No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils.

Authors:  M A Sovershaev; K F Lind; H Devold; T Ø Jørgensen; J-B Hansen; B Østerud; E M Egorina
Journal:  J Thromb Haemost       Date:  2008-07-28       Impact factor: 5.824

Review 9.  Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective.

Authors:  Maiara Marx Luz Fiusa; Marco Antonio Carvalho-Filho; Joyce M Annichino-Bizzacchi; Erich V De Paula
Journal:  BMC Med       Date:  2015-05-06       Impact factor: 8.775

Review 10.  Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI.

Authors:  Ana Carolina P Souza; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2015-02-18       Impact factor: 10.612

View more
  5 in total

1.  Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy.

Authors:  Marcel Levi; Jean-Louis Vincent; Kosuke Tanaka; Amanda H Radford; Toshihiko Kayanoki; David A Fineberg; Debra Hoppensteadt; Jawed Fareed
Journal:  Crit Care Med       Date:  2020-06-11       Impact factor: 7.598

2.  The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity.

Authors:  Inmaculada Serrano; Ana Luque; Francesca Mitjavila; Anna M Blom; Santiago Rodríguez de Córdoba; M Cristina Vega; Joan Torras; Josep M Aran
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

3.  Respiratory tract infection and risk of bleeding in oral anticoagulant users: self-controlled case series.

Authors:  Haroon Ahmed; Heather Whitaker; Daniel Farewell; Julia Hippisley-Cox; Simon Noble
Journal:  BMJ       Date:  2021-12-21

4.  Compass in COVID-19 Illness: Disseminated Intravascular Coagulation/Sepsis-induced Coagulopathy Scoring in Predicting Severity.

Authors:  Kapil G Zirpe; Shrirang N Bamne
Journal:  Indian J Crit Care Med       Date:  2021-12

5.  Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy.

Authors:  Marcel Levi; Jean-Louis Vincent; Kosuke Tanaka; Amanda H Radford; Toshihiko Kayanoki; David A Fineberg; Debra Hoppensteadt; Jawed Fareed
Journal:  Crit Care Med       Date:  2020-08       Impact factor: 9.296

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.